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The effects of heterologous gene dosage as well as Salmonella typhimurium strain variability on immune
response toward both the heterologous antigen, the nontoxic mutant of the Escherichia coli heat-labile entero-
toxin LTK63, and the carrier Salmonella strain have been analyzed. Effects of a single integration into the host
DNA and different-copy-number episomal vectors were compared in S. typhimurium Dcya Dcrp Dasd strains of
two different serotypes, UK-1 and SR-11. Expression of the enterotoxin in the different Salmonella isolates in
vitro was found to vary considerably and, for the episomal vectors, to correlate with the plasmid copy number.
LTK63-specific serum immunoglobulin G (IgG) and mucosal immunoglobulin A (IgA) antibodies were highest
in mice immunized with the high-level-expression strain. High anti-LTK63 IgG and IgA titers were found to
correspond to higher anti-Salmonella immunity, suggesting that LTK63 exerts an adjuvant effect on response
to the carrier. Statistically significant differences in anti-LTK63 immune response were observed between
groups of mice immunized with the attenuated Dcya Dcrp UK-1 and SR-11 derivatives producing the antigen
at the same rate. These data indicate that the same attenuation in S. typhimurium strains of different genetic
backgrounds can influence significantly the immune response toward the heterologous antigen. Moreover,
delivery of the LTK63 enterotoxin to the immune system by attenuated S. typhimurium strains is effective only
when synthesis of the antigen is very high during the initial phase of invasion, while persistence of the
S. typhimurium strain in deep tissues has only marginal influence.
Enterotoxigenic Escherichia coli strains produce a plasmid-
encoded heat-labile enterotoxin (LT) (15, 34) related to chol-
era toxin (CT) (9, 35). LT is composed of two subunits, A and
B, which are exported to the periplasmic space, where they
assemble into an AB5 multimeric complex (16). Several mu-
tants of LT-A have been constructed, and in particular, a
nontoxic mutant which contains a substitution of serine 63 with
lysine (LTK63) has been shown to maintain the structural and
immunogenic properties of wild-type LT (21, 27, 28). LTK63
has also been found to display the strong mucosal adjuvant
activity pertaining to wild-type LT. Efficient induction of mu-
cosal immune response, specifically in the mouse vagina, has
been achieved via the intranasal route of immunization (10).
For the development of oral vaccines, however, it would be
desirable to exploit the properties of LTK63 for enhancing
antigen-specific immune response in the intestinal mucosa by
means of oral delivery of the potent mucosal adjuvant.
Oral delivery of antigens by live vaccines is known to lead to
a more effective production of antigen-specific antibodies in
mucosal secretions than oral administration of the soluble an-
tigen (36, 39). Several antigen delivery systems which use as
carriers mutant intracellular pathogens that have lost the abil-
ity to persist and produce the disease while retaining limited
growth in vivo have been developed. In particular, attenuated
Salmonella mutants are suitable immunological carriers for
virulence determinants from other enteric bacteria in that they
can induce humoral immune response selectively at the site of
colonization, the gut mucosa. Vaccine strains of Salmonella
have been successfully attenuated by introducing different
types of mutations (5, 8, 23, 26). Notably, Salmonella strains
with a galactose epimerase (galE) mutation (18) or deletions in
genes for the biosynthesis of aromatic compounds (aro mu-
tants) (11, 12, 17, 19) or in the adenylate cyclase (cya) and
cyclic AMP receptor protein (crp) genes (6) are the most
extensively characterized.
Delivery of the B subunit of the E. coli enterotoxin (LT-B)
by a galE mutant of Salmonella typhimurium has been shown to
elicit low levels of anti-LT-B serum and mucosal antibodies.
Since the vector used for expression of LT-B was rapidly lost in
vivo, i.e., in the absence of the antibiotic required for selection
of the plasmid, the level of immune response could be corre-
lated only with the amount of antigen expressed during the
initial phase of invasion (3).
Recently, direct comparison between the aroA aroD/pnirB
and the Dcya Dcrp Dasd/asd1 delivery systems for the ability to
induce humoral and cellular immunity after a single immuni-
zation showed that the former vaccine strain had greater po-
tential as a carrier for antigen delivery (20). However, the
balanced lethal asd system for in vivo selection of plasmids
expressing heterologous antigens in the attenuated Dcya Dcrp
Dasd strains is still very attractive in that asd1 plasmids do not
require antibiotic resistance markers for selection while stably
maintained in vivo (24). In addition, the Dcya Dcrp Dasd/asd1
delivery system has been reported to induce protective immu-
* Corresponding author. Mailing address: IRIS, Chiron Vaccines,
Via Fiorentina 1, 53100 Siena, Italy. Phone: (577) 243485. Fax: (577)
243564. E-mail: galeotti@iris02.biocine.it.
† Present address: Departamento de Genética e Evolução, Instituto
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nity against several pathogens (25, 29, 40). Most of these stud-
ies have restricted analysis of the immune response to antigens
expressed from the same asd1 plasmid carried by Dcya Dcrp
Dasd mutants usually of the same S. typhimurium serotype. In
this work, we have analyzed the influence of heterologous gene
dosage, and thus level of expression, as well as S. typhimurium
strain variability on immune response toward both the heter-
ologous antigen, a nontoxic mutant of E. coli LT, and the
carrier Salmonella strain. Effects of a single integration into the
host DNA and episomal vectors at different copy numbers
were compared in S. typhimurium strains of two different Dcya
Dcrp Dasd serotypes, UK-1 and SR-11.
MATERIALS AND METHODS
Strains, plasmids, and media. The bacterial strains and plasmids used are
listed in Table 1. The Dcya Dcrp Dasd S. typhimurium strains were kindly provided
by Roy Curtiss III, Washington University, St. Louis, Mo.
The complex medium used for routine bacterial growth was Luria broth (LB)
medium. The minimal medium used was that described by Curtiss and Kelly (6).
When required, the antibiotics ampicillin, chloramphenicol, tetracycline, and
nalidixic acid were added to culture media at concentrations of 100, 50, 30, 12.5,
and 40 mg per ml, respectively. For growth of the Dasd Salmonella strains, the
amino acids methionine (20 mg/ml), threonine (8 mg/ml), isoleucine (20 mg/ml),
and/or diaminopimelic acid (50 mg/ml) were added to the culture media.
For immunization experiments, bacteria from static overnight cultures were
diluted 1:20 in prewarmed LB and grown at 37°C under aeration to give 109
CFU/ml. CFU were determined by plating serial dilutions of cultures of LB agar
plates or Difco MacConkey base supplemented with 1% maltose and nalidixic
acid for strains x4072 and x4217.
DNA manipulations. Extraction and purification of plasmid DNA were carried
out as described by Sambrook et al. (31). Genomic DNA extraction was per-
formed as described by Rossolini et al. (30). Southern blot experiments were
performed by bidirectional transfer of DNA from agarose gels to nylon mem-
branes. Specific DNA probes were obtained amplifying DNA sequences by PCR
and labeled with [a-32P]dATP, using the random-primers method.
The pBluescript KS plasmids containing the wild-type elt or the eltK63 mutated
gene (provided by M. Pizza) were described previously (28). The 2-kb BamHI-
SalI fragment carrying elt or eltK63 was subcloned into the pYA3074, pYA3149,
and pYA3137 asd vectors (provided by R. Curtiss III). The resulting plasmids
were transformed and amplified in E. coli x6212 and then purified and trans-
formed into the attenuated S. typhimurium strains. Transformants were selected
in LB medium. The fermentation pattern, auxotrophic requirements, and lipo-
polysaccharide content were routinely analyzed in all strains. The completely
smooth lipopolysaccharide was examined by polyacrylamide gel electrophoresis
(PAGE) and silver staining after periodic acid treatment (38).
The number of copies per cell of each construct was determined by Southern
blot analysis of total DNA extracted from the different strains, digested with
BamHI and SalI, and hybridized to an elt-specific probe and to a probe specific
for the spvC gene of S. typhimurium. The relative intensity of the elt-specific band
was calculated by using a densitometer (Ultroscan; LKB).
The nucleotide sequence of mini-Tn5 asd eltK63 insertions was determined
from DNA fragments obtained by inverse PCR. Briefly, SalI-XhoI-digested
genomic DNA fragments were incubated with T4 DNA ligase overnight at 15°C.
Inverse PCR was performed by using an Expand 20 kbplus PCR kit (Boehringer)
in a total volume of 50 ml with 6 ng of DNA (2 ml of the ligation mixture) as a
template and 300 nM each of the following primers: 59-ACAGACGTGAGCC
TGAAAGGTTTGG-39 and 59-CTTCCACTACAGGGAGCTGTTATAGC-39
(complementary to the promoter and to the 39 end of the coding region of eltK63,
respectively).
SDS-PAGE and immunoblot analysis. Bacterial cultures were grown to the
logarithmic or stationary phase in LB broth. Cells were collected and lysed by
boiling (5 to 10 min) in LSB buffer (2% sodium dodecyl sulfate [SDS], 10%
glycerol, 100 mM dithiothreitol, 62.5 mM Tris-HCl [pH 6.8]). Total proteins in
cell extracts were quantified with a micro-bicinchoninic acid protein assay re-
agent kit (Pierce, Rockford, Ill.). Proteins were separated by SDS-PAGE (15%
polyacrylamide gel) and transferred to nitrocellulose membranes. Mouse poly-
clonal anti-LT antiserum was used as the primary antibody. Bands were visual-
ized by enhanced chemiluminescence (Amersham Life Science) or with 4-chloro-
1-naphthol (Sigma) as the substrate. Evaluation of the amount of LT produced
by the different strains was obtained by densitometric analysis of bands, using
purified enterotoxin or CT as a reference.
Immunization and sampling. Groups of five or seven 6- to 8-week-old female
BALB/c mice (Charles River, Calco, Como, Italy) were immunized intragastri-
cally with two or four doses containing ca. 8 3 108 CFU of each Salmonella
strain. Mice were deprived of water and food for 12 h and fed with 30 ml of 0.2
M sodium bicarbonate to neutralize stomach acidity 30 min prior to immuniza-
tion. Groups of mice were immunized on days 0 and 10 to 14 or on days 0, 10,
17, and 24.
Serum samples and intestinal mucus were collected on days 14, 17, 24, 36, 50,
and 66. Blood samples were collected from the retro-orbital sinus of each anes-
thetized mouse. To collect gut secretions, mice were sacrificed, the small intes-
tine was excised, and the mucus was scraped from the luminal surface. Mucus
samples were collected in centrifuge tubes containing 5 ml each of 0.1 M phe-
nylmethylsulfonyl fluoride in ethanol, 1% bovine serum albumin, and 1% sodium
azide. After centrifugation at 12,000 3 g for 10 min at 4°C, supernatant fluids
were collected, 5 ml of a solution containing 0.1 M phenylmethylsulfonyl fluoride
and 1% sodium azide was added, and samples were stored at 220°C.
Spleens and Peyer’s patches were removed from sacrificed animals and pro-
cessed as described by Curtiss and Kelly (6). After disruption in a Dounce tissue
homogenizer, suspensions were diluted in phosphate-buffered saline (PBS) and
plated on MacConkey agar containing 1% lactose. The expected phenotype of
S. typhimurium strains recovered from immunized animals was verified on Mac-
Conkey agar supplemented with 1% maltose.
ELISA for LT and Salmonella. Individual mouse serum and mucus samples
were tested for immunoglobulin A (IgA) and IgG antibodies against LT or whole
Salmonella cells by enzyme-linked immunosorbent assay (ELISA). A PBS solu-
tion of purified LT (a gift from M. Pizza) was absorbed to 96-well ELISA plates
(Greiner-GmbH, Kremsmunster, Austria) at 0.2 mg per well overnight at 4°C.
For anti-Salmonella antibody titration, bacteria were grown overnight, harvested
by centrifugation, and resuspended in PBS at 3 3 1011 CFU/ml. Bacteria were
TABLE 1. Bacterial strains and plasmids used
Strain or plasmid Relevant genotype or phenotype Reference orsource
Strains
E. coli x6212 F80d lacZ DM15 deoR D(lacZYA-argF)U169 supE44 l2 gyrA recA1 relA1 endA1
DasdA4 D[zhf-2::Tn10] hsdR17 (r2 m1)
R. Curtiss III
S. typhimurium
x4072 SR-11 pStSR1002 gyrA1816 Dcya-1 Dcrp-1 DasdA1 D(zhf-4::Tn10) 24
x4217 SR-11 pStSR1011 gyrA1816 Dcya-1 Dcrp-1 DasdA1 D(zhf-4::Tn10) 33
x3985 UK-1 pStV11 Dcya-12 D(zid-62::Tn10) Dcrp-11 D(zhb::Tn10) 7
x3987 UK-1 pStV11 Dcya-12 D(zid-62::Tn10) Dcrp-11 D(zhc-1431::Tn10) DasdA1 D(zhf-4::Tn10) 14
x4217-10E x4217 with insertion of mini-Tn5 asd elt-K63 2
x3987-18A x3987 with insertion of mini-Tn5 asd elt-K63 2
Plasmids
pBluescript KS-LT E. coli vector with LT gene inserted into the SmaI-HindIII sites 28
pBluescript KS-
LTK63
E. coli vector with mutant LTK63 gene inserted into the SmaI-HindIII sites 28
pYA3074 Low-copy-number Asd1 vector with pSC101 replicon R. Curtiss III
pYA3149 Medium-high-copy-number Asd1 vector with pBR322 replicon R. Curtiss III
pYA3137 High-copy-number Asd1 vector with pUC replicon R. Curtiss III
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heat killed for 10 min at 80°C and stored at 220°C. Each sample well was coated
with 0.1 ml of this suspension diluted 100-fold in 0.1 M carbonate buffer (pH 9.6).
Plates were blocked with PBS containing 0.05% Tween 20 and 1% bovine serum
albumin for 2 h at 37°C. After washing with PBS, an anti-isotype secondary
antibody (Sigma) was added and plates were incubated for 2 h at 37°C. Serum
samples were incubated with alkaline phosphatase-conjugated goat anti-mouse
IgG (g-chain specific) antibodies, mucus samples were incubated with biotin-
conjugated goat anti-mouse IgA (a-chain specific) antibodies. Plates were
washed with PBS, developed with a solution of p-nitrophenyl phosphate (1
mg/ml) in 1 M diethanolamine buffer (pH 9.8), and read in an ELISA reader
(Titertek Multiscan) at 405 nm. Titers were expressed as the last dilution that
gave an optical density at 405 nm of 0.1. Under these experimental conditions,
preimmune samples always gave an optical density at 405 nm of ,0.1 from the
first dilution.
Nucleotide sequence accession number. The nucleotide sequence of the mini-
Tn5 insertion in the virulence plasmid described in this work has been assigned
GenBank accession no. AF025956.
RESULTS
Influence of copy number on expression level of LT-K63 in
vitro. Expression of LTK63 by S. typhimurium attenuated
strains carrying the eltK63 gene cloned into the pYA plasmids
listed in Table 1 was examined. Western blot analysis of total-
cell extracts and periplasmic fractions from logarithmic- and
stationary-growth-phase cultures of the different S. typhimurium
strains showed, as expected, a good correlation between the
amount of LTK63 produced by each strain and the copy num-
ber of the recombinant plasmid carried by the strain. Expres-
sion of the enterotoxin gene, which is under the control of its
own promoter in these constructs, was constitutive in all strains
analyzed and in all conditions tested.
Representative results are shown in Fig. 1a. A fivefold dif-
ference was observed between the amount of toxin synthesized
by strain x3987:pYA3074-LTK63 (Fig. 1a, lane 3) and that
produced by x3987:pYA3137-LTK63 (Fig. 1a, lane 5). The
medium-high-copy-number plasmid pYA3149, in turn, could
direct synthesis of LTK63 at a level slightly lower than that
found for the high-copy-number plasmid pYA3137 in the same
strain (Fig. 1a; compare lanes 4 and 5). However, some differ-
ences were found between the strains in that x4072:pYA3137-
LTK63 produced the same amount of enterotoxin as x4072:
pYA3149-LTK63 but showed an unusual growth curve with a
3-h lag phase followed by an exponential growth phase with the
same doubling time as the other strains. Furthermore, it is
noteworthy that strain x4072:pYA3137-LTK63 lysed during
static growth.
To assess if the phenotype conferred to strain x4072 by
plasmid pYA3137-LTK63 was due to the presence of the high-
copy-number plasmid or to toxicity of LTK63, a preliminary
analysis of the attenuated strains carrying plasmid pYA3137
with and without the eltK63 insert was carried out by plating
cells from static growth onto selective medium. Lysis was ob-
served only for strain x4072 containing the eltK63 insert in
plasmid pYA3137. The plasmid without the insert did not
cause lysis in any of the strains analyzed (data not shown).
Likely, expression of eltK63 from the high-copy-number plas-
mid is toxic for strain x4072 during static growth.
Two S. typhimurium strains, x3987-18A and x4217-10E, car-
rying a single-copy integration of the eltK63 gene into the
genome and producing equally high amounts of LTK63, were
also analyzed for expression of the enterotoxin. The two strains
were obtained by inserting a single copy of a mini-Tn5 asd
eltK63 minitransposon into the genomes of S. typhimurium
x3987 and x4217. It should be noted that strain x4217 is an
SR-11 derivative (33), while strain x3987 is a derivative of the
S. typhimurium UK-1 strain x3985 (14). Insertion of the mini-
Tn5 asd eltK63 was found to have occurred in the same locus
of the virulence plasmid in both strains x3987-18A and x4217-
10E. The nucleotide sequence of this locus at the junction of
the O end of the minitransposon was determined from DNA
fragments obtained by inverse PCR. The locus does not show
any homology to known S. typhimurium sequences (Fig. 1c).
In Fig. 1a, lane 2, the level of LTK63 production of strain
x3987-18A is compared with those of the episomal systems
used for expression in the same strain. The amount of LTK63
found in the single-copy integrant was threefold greater than
that observed for the low-copy-number plasmid pYA3074. Fig-
ure 1b shows a direct comparison of the level of LTK63 ex-
pression in late-logarithmic-growth-phase cultures of the
eltK63 single-copy integrants.
It was also found that in all strains analyzed, the LT was
secreted to the periplasmic space (data not shown), where
presumably it is assembled into its heterohexameric form, as it
has been shown that assembly of LT takes place in the peri-
plasm in E. coli (16).
Serum antibody response induced by S. typhimurium x3987
expressing different levels of LTK63. Groups of five BALB/c
mice were immunized orally with strain x3987 containing the
low-copy-number plasmids pYA3074-LT and pYA3074-LTK63
or the high-copy-number plasmid pYA3137-LTK63. The same
strain carrying the pYA3074 vector without the LTK63 insert
and the parental attenuated asd1 strain x3985 were used as
control strains. A single oral booster dose of 8 3 108 S. typhi-
murium cells was administered 10 days after the first inocula-
tion. The Salmonella-specific IgG titers in serum samples from
immunized animals 24, 36, and 66 days after the first dosing
were found to differ significantly particularly at day 24, in that
strain x3987:pYA3137-LTK63 induced an average 10-fold-
higher response. A diminished, but still significant, difference
was observed at day 66 (Fig. 2). A possible explanation for the
FIG. 1. Western blot analysis of expression of LTK63 in different S. typhi-
murium strains, using an anti-LT antibody. (a) Total-cell extracts of stationary-
growth-phase cultures of strains x3987 (lane 1), x3987-18A (lane 2), x3987:
pYA3074-LTK63 (lane 3), x3987:pYA3149-LTK63 (lane 4), and x3987:
pYA3137-LTK63 (lane 5); (b) total-cell extracts of late-logarithmic-growth-
phase cultures of eltK63 single-copy integrants. Total proteins in cell extracts
were quantified, and 30 mg of each sample was used for the immunoblot. Purified
CT (3 mg) and LT (3 mg) were used as a control and as a molecular mass marker
for the A, A1, and B subunits of the toxins. (c) Nucleotide sequence of the
integration site of the mini-Tn5 asd eltK63 into the virulence plasmid of strains
x3987-18A and x4217-10E. The sequence of the mini-Tn5 19-bp O end flanking
the eltK63 promoter (PeltK63; arrow) is boxed.
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less pronounced difference at day 66 in mice receiving the
high-copy-number plasmid strain could be that the higher anti-
Salmonella titers elicited by this strain after the first immuni-
zation result in a reduced number of organisms able to colo-
nize after the second inoculum.
No significant difference was observed between the antibody
responses induced by strains x3987:pYA3074-LT and x3987:
pYA3074-LTK63. When the anti-Salmonella IgG titers in-
duced by the two control strains are compared, it should be
noted that the asd mutation present in strain x3987 further
attenuates S. typhimurium. Thus, the higher anti-Salmonella
IgG titers elicited by the asd1 strain x3985 are presumably due
to a higher persistence of this strain in deep organs (Table 2).
Analysis of LT-specific IgG titers in the same serum samples
was carried out only for the three x3987 strains containing the
LT or LTK63 construct. IgG titers were found to be negligible
with both low-copy-number constructs, while samples from
mice immunized with the high-copy-number plasmid-bearing
strain x3987:pYA3137-LTK63 showed high anti-LT IgG titers
at days 24 (1:10,310), 36 (1:31,310), and 66 (1:20,970).
Influence of Salmonella genetic background on the induction
of serum antibody response. A similar immunization scheme
was extended to include oral inoculation of groups of seven
BALB/c mice with 8 3 108 cells of the three S. typhimurium
strains carrying a single-copy insertion of the mini-Tn5 asd
eltK63 minitransposon into the genomes of S. typhimurium
x3987 and x4217 (Table 1).
The LT-specific and Salmonella-specific IgG titers deter-
mined in serum samples from mice immunized with these
strains are shown in Fig. 3A. While the anti-Salmonella serum
responses were similar for the two strains, a significant differ-
ence was observed in the anti-LT titers, particularly at day 66
from immunization. Sera from mice immunized with strain
x3987-18A showed LT-specific IgG titers 10- to 100-fold
higher than those in samples from the other group of mice. It
is interesting that this occurs in spite of the fact that persis-
tence of this S. typhimurium strain in deep organs 50 days after
immunization was found to be over 10-fold lower than that of
strain x4217-10E (Table 2) and that the levels of LTK63 pro-
FIG. 2. Influence of amounts of LT or LTK63 synthesized by S. typhimurium on anti-Salmonella immune response. Serum IgG activity to S. typhimurium in mice
immunized with two doses of strain x3987 containing the low-copy-number plasmids pYA3074-LT and pYA3074-LTK63, the high-copy-number plasmid pYA3137-
LTK63, or the control plasmid pYA3074 without the enterotoxin gene insert was determined. The two doses were given to groups of five mice on days 0 and 10. IgG
responses were detected by ELISA 24, 36, and 66 days after primary immunization. The standard error of the mean was calculated for all data, and mean values were
compared by Student’s t test. P values of #0.0001 were considered statistically significant.




24 dpi 50 dpi 24 dpi 50 dpi
x3985 1.1 3 104 0.8 3 101 1.7 3 104 2.4 3 103
x3987-18A 5.2 3 103 0 6.3 3 103 7.5 3 101
x4217-10E 4.6 3 103 1.2 3 102 9.9 3 103 9.5 3 102
x3987:pYA3137/LT-K63 1.1 3 103 1.0 3 101b 2.7 3 103 1.3 3 102b
x3987:pYA3149/LT-K63 1.8 3 103 0b 1.4 3 103 0b
x4072:pYA3149/LT-K63 2.9 3 103 0.3 3 101b 1.7 3 102 0.2 3 101b
a Groups of seven BALB/c mice were inoculated intragastrically with two
doses of 8 3 108 S. typhimurium organisms. Peyer’s patches and spleens were
removed at specified days postimmunization (dpi), homogenized in PBS, and
plated on MacConkey agar containing 1% lactose.
b Recovery of S. typhimurium from Peyer’s patches and spleens of mice im-
munized with four doses of 8 3 108 S. typhimurium organisms.
VOL. 66, 1998 ADJUVANTICITY OF LT IN S. TYPHIMURIUM 227
 on A


















duced in vitro were equally high for the two strains (Fig. 1b).
Possibly, this may be attributed to a difference in the level of
expression of LTK63 in vivo during the initial steps of in-
vasion.
Differential induction of serum antibody response by high
LTK63 expression. Since the amount of enterotoxin produced
by S. typhimurium seemed the most crucial parameter in de-
termining a good immune response, an immunization experi-
ment was carried out with four doses of the S. typhimurium
strains containing the pYA3149-LTK63 and pYA3137-LTK63
constructs. The strains carrying the medium-high-copy-number
plasmid were included in this experiment since strain x4072:
pYA3137-LTK63 lysed after growth in static culture. In addi-
tion, in order to compare this immunization scheme with the
previous ones, groups of seven mice were inoculated with only
two doses of the same plasmid-bearing S. typhimurium strains
used for immunizing mice with four doses. The immune re-
sponse in these animals was evaluated only at day 66 from the
first inoculum. The results presented in Fig. 4A show that both
the anti-LTK63 and the anti-Salmonella IgG titers were high-
est for the group of mice immunized with strain x3987:
pYA3137-LTK63.
FIG. 3. ELISA analysis of immune response induced by two different genetic backgrounds carrying LTK63 single-copy integrations. Groups of seven mice were
inoculated with the two S. typhimurium strains on days 0 and 14. Samples were collected at 24, 36, and 66 days after primary immunization. (A) Serum anti-LTK63 and
anti-Salmonella IgG antibody response; (B) mucosal anti-LTK63 and anti-Salmonella IgA titers. Mean values of each group were compared by Student’s t test. P values
of #0.05 were considered statistically significant.
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FIG. 4. ELISA analysis of immune response induced by UK-1 (x3987) and SR-11 (x4072) strains expressing high levels of LTK63. Groups of seven mice were
immunized with two (on days 0 and 10) or four doses (on days 0, 10, 17, and 24) of strains x3987:pYA3137-LTK63, x3987:pYA3149-LTK63, and x4072:pYA3149-
LTK63. Samples were collected at day 66 after primary immunization from mice immunized with two doses (66*) and at 24 and 66 days from mice immunized with
four doses. (A) Serum anti-LTK63 or anti-Salmonella total IgG titers; (B) mucosal anti-LTK63 or anti-Salmonella total IgA titers. Mean values of each group were
compared by Student’s t test. P values of #0.001 (A) and #0.01 (B) were considered statistically significant.
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Analysis of mucosal antibody response. Intestinal mucus
samples from mice immunized with the S. typhimurium strains
reported in Table 2 were analyzed for LTK63-specific and
Salmonella-specific IgA responses. The mean IgA titers of each
group of seven mice are shown in Fig. 3B and 4B. The anti-
LTK63 secretory response was clearly higher in mice inocu-
lated with the medium-high- and high-episomal-expression
constructs (Fig. 4B) than in mice immunized with the eltK63
integrants (Fig. 3B), with the exception of the group immu-
nized with strain x3987-18A. The high anti-LTK63 IgA titers in
the latter group of mice correlate well with the anti-LTK63
serum IgG titers found in the same group (Fig. 3A), although
the variation of titers in individual mice was greater for the IgA
samples than for the IgG samples.
A correlation was observed also between the anti-Salmonella
IgG (Fig. 4A) and IgA titers (Fig. 4B) of mice immunized with
four doses of the strains carrying plasmid pYA3149-LTK63
or pYA3137-LTK63. Animals inoculated with strain x3987:
pYA3137-LTK63 always showed higher systemic and local im-
mune responses than the other two groups of mice. Moreover,
after the fourth immunization, higher IgG titers were paral-
leled by higher IgA titers in all groups (Fig. 4, day 66).
The stability in vivo of the eltK63 constructs was assessed by
Southern blot analysis of genomic or plasmid DNA extracted
from bacteria isolated from Peyer’s patches and spleens of
immunized animals. All strains were found to have maintained
the eltK63 construct. Western blot analysis of cell extracts from
the same S. typhimurium isolates also confirmed that the level
of LTK63 synthesis was unchanged after the passage in vivo
(data not shown).
DISCUSSION
As most studies on attenuated Salmonella carriers have an-
alyzed differences in the induction of immunity between levels
of antigen expression (3, 4), selection for vector maintenance
in vivo, or attenuation of the delivery system (20, 37), we have
compared the immune responses induced by the same antigen
when delivered by different strain-plasmid combinations. In
particular, we have analyzed a single integration into the host
DNA and multicopy episomal vectors in three Dcya Dcrp Dasd
strains of different genetic backgrounds expressing a nontoxic
mutant of the E. coli LT.
A first comparison of variation in antigen delivery by the
same S. typhimurium strain in relation to different expression
levels of the antigen was made by analyzing the systemic re-
sponse in mice immunized with strain x3987 containing the
low- and high-expression constructs. The lack of an LTK63-
specific immune response in mice immunized with the low-
expression construct, in contrast to high levels of IgG antibod-
ies elicited by the high-expression vector, correlates with a
fivefold difference in amount of LTK63 synthesized in vitro by
the two constructs. This finding suggests that for this S. typhi-
murium strain, the threshold for induction of anti-LTK63 sys-
temic response is high (see below). Alternatively, expression in
vivo of LTK63 from the two plasmids may not correlate with
what is seen in vitro, although expression in both constructs is
driven by the same promoter.
An interesting finding of this experiment is that strain x3987:
pYA3137-LTK63 induced anti-Salmonella IgG titers signifi-
cantly higher, during the first 3 to 5 weeks postimmunization,
than those induced by control strains or by low LTK63 pro-
ducers. LTK63 has been previously shown to exert an adjuvant
effect on immune response to different antigens administered
to mice by different routes (10).
By comparing S. typhimurium strains with different genetic
backgrounds and expressing the same amount of LTK63 from
a single integration site, the influence of strain variability could
be inferred from the anti-LTK63 antibody response, while both
systemic and local immune responses to Salmonella were not
significantly different for the different strains. Only strain
x3987-18A could elicit high LTK63-specific IgG and IgA titers.
Considering that strain x4217-10E contains the eltK63 gene
integrated in the same locus of the virulence plasmid as strain
x3987-18A and can persist longer in deep tissues, this result
implies that very early events at the priming of the immune
response are particularly critical in the induction of an anti-LT
immune response (4). Furthermore, the x3987-18A genetic
background may be intrinsically more effective in priming anti-
LTK63 immune responses. The observation that high expres-
sion of the antigen is crucial during the early phase of the
induction of the immune response is consistent with the finding
by others that oral administration of Salmonella strains ex-
pressing LT-B induces a dramatic increase in the level of
mRNA of some cytokines (e.g., interleukin-12) at mucosal sites
within hours following immunization (1).
One of the advantages of the Dcya Dcrp/asd system is the
effectiveness of the asd selection for plasmid maintenance in
vivo (7, 13, 24). As previously shown by other reports, the
stability in vivo of the asd vectors used in this study for expres-
sion of LTK63 was found to be very high even for the high-
copy-number plasmid pYA3137. It should be noted, however,
that expression of LTK63 from the latter plasmid conferred an
unusual phenotype to strain x4072 in vitro: lysis after static
growth. For this reason, the analysis of immune response had
to be extended to strains containing the medium-high-copy-
number plasmid pYA3149. Comparison between both systemic
and local antibody responses induced by UK-1 and SR-11
strains expressing LTK63 from the high- or the medium-high-
copy-number plasmids clearly showed that, in addition to any
influence of the S. typhimurium strain delivering the antigen,
the level of expression of the heterologous antigen is critical
for a high immune response. A 2-fold difference in amount of
LTK63 produced by strain x3987:pYA3137-LTK63 was suffi-
cient to enhance both IgG and IgA titers 10-fold. An adjuvant
effect of LTK63 could be inferred also from these data, since
higher Salmonella-specific titers correlated with higher expres-
sion of LTK63.
In conclusion, our data indicate that the same attenuation in
different genetic background S. typhimurium strains, expressing
the recombinant antigen at the same level, can produce signif-
icantly different immune responses. Moreover, delivery of the
LTK63 antigen to the immune system by attenuated S. typhi-
murium strains is effective only when synthesis of the antigen is
very high during the initial phase of invasion, while persistence
of the S. typhimurium strain in deep tissues has only marginal
influence.
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